Transcriptomics

Dataset Information

0

Fibrotic and Immune Pathway Signatures in Systemic Sclerosis Suggest a Progressive, Multi-step Model of Disease Pathogenesis


ABSTRACT: Pathway expression analysis in systemic sclerosis revealed key mediators driving pathology within each of the intrinsic gene expression subsets. Genome-wide expression profiling in systemic sclerosis (SSc) has identified four 'intrinsic' subsets of disease (fibroproliferative, inflammatory, limited, and normal-like), each of which appear to be driven by distinct signaling pathways. Here we examine experimentally derived gene expression signatures for thirteen agonists to better understand the molecular mechanisms underlying each intrinsic subsets. Pathway-specific gene signatures were compared against skin biopsy microarray data consisting of 329 microarray hybridizations from 287 unique biopsies representing 111 patients. Hierarchical clustering recapitulated the four SSc 'intrinsic' gene expression subsets, along with an intermediate subset exhibiting both inflammatory and fibroproliferative gene expression signatures. The fibroproliferative subset is most strongly associated with the PDGF gene signature, while the inflammatory subset demonstrated strong activation of NF-kappaB, characterized by early induction of TH2 signals, which transitions to a more TH17-like immune response over time. The limited subset was associated with IFNalpha signaling, combined with strong downregulation of PDGF signaling. The inflammatory-proliferative subset shows downregulation of NF-kappaB-associated pathways in conjunction with increased PDGF signaling, suggestive of a transitional state linking the inflammatory and fibroproliferative subsets. IL-13 signaling was strongly associated with early disease, while TGFbeta signaling was associated with more severe disease. Together these data suggest a multi-step, progressive model of disease pathogenesis driven by distinct pathways. Targeting these pathways based upon a patient's underlying disease subset should improve therapeutic outcomes.

ORGANISM(S): Homo sapiens

PROVIDER: GSE56308 | GEO | 2015/04/01

SECONDARY ACCESSION(S): PRJNA244937

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-04-01 | E-GEOD-56308 | biostudies-arrayexpress
2012-03-23 | E-GEOD-32413 | biostudies-arrayexpress
2023-02-01 | GSE217067 | GEO
2012-03-23 | GSE32413 | GEO
2015-08-13 | E-GEOD-71991 | biostudies-arrayexpress
2015-08-13 | E-GEOD-71995 | biostudies-arrayexpress
2015-08-13 | E-GEOD-71998 | biostudies-arrayexpress
2015-08-13 | GSE71991 | GEO
2015-08-13 | GSE71998 | GEO
2015-08-13 | GSE71995 | GEO